Roche expands hepatitis diagnostics portfolio to help

Elecsys® HBeAg quant is an immunoassay that can be used as an early marker of acute hepatitis B infection, as well as an indicator of chronic active...

Related Keywords

Switzerland ,Japan ,United States ,Sileia Urech ,Clin Virol ,Nathalie Altermatt ,Matt Sause ,Elecsys Hbeag ,Simon Goldsborough ,Kirti Pandey ,Karsten Kleine ,Rebekka Schnell ,Roche Group Media Relations ,Roche Group ,Clin Lab Anal ,Genentech ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Infect Dis ,Englj Med ,Swiss Stock Exchange Ro ,F Hoffmann La Roche Ltd ,